Related Experiment Video

Updated: Jun 10, 2026

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
09:32

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Published on: September 26, 2019

Investigational and unproven therapies in atopic dermatitis

Peck Y Ong1, Mark Boguniewicz

  • 1Division of Clinical Immunology and Allergy, Childrens Hospital Los Angeles, Los Angeles, CA 90027, USA.

Immunology and Allergy Clinics of North America
|July 31, 2010
PubMed

Insights

Atopic dermatitis is a chronic skin condition that significantly impacts quality of life. New research explores novel therapeutic targets for moderate to severe cases, focusing on immune system and skin barrier abnormalities.

Area of Science:

  • Dermatology
  • Immunology
  • Pharmacology

Background:

  • Atopic dermatitis (AD) presents a chronic, relapsing course, causing significant morbidity.
  • Current treatments for moderate-to-severe AD may have side effects and raise patient/caregiver concerns.
  • Understanding AD pathogenesis involves barrier defects and immune system abnormalities.

Purpose of the Study:

  • To review recent advances in understanding atopic dermatitis.
  • To identify novel therapeutic targets for managing moderate to severe atopic dermatitis.
  • To explore new treatment strategies beyond current standards of care.

Main Methods:

  • Literature review of recent scientific advances in atopic dermatitis.
  • Analysis of emerging therapeutic targets based on immunological and barrier defect research.
  • Synthesis of information on novel interventions for AD.

Main Results:

  • Advances in understanding skin barrier defects offer new therapeutic avenues.
  • Innate and adaptive immune system abnormalities in AD provide targets for intervention.
  • Emerging strategies include antimicrobial peptides, anti-toxin approaches, and cytokine inhibition.

Conclusions:

  • Novel therapeutic targets for atopic dermatitis are emerging from recent research.
  • These targets include modulating immune responses and addressing barrier dysfunction.
  • New treatments hold promise for improving outcomes in moderate to severe atopic dermatitis.

Related Concept Videos

Acne Infection01:27

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...